Dr. Liang Cheng is the Professor of Pathology and Surgery/Urology, Vice Chair for Translational Research, Director of Anatomic Pathology, Director of Molecular Pathology in the Department of Pathology and Laboratory Medicine at the Brown University Warren Alpert Medical School | Lifespan Health. He is also the Associate Director for Shared Resources, the Legorreta Cancer Center at Brown University, Providence, Rhode Island. Dr. Cheng has published over 1,200 peer-reviewed SCI articles (citations, 66,500; h-index: 127; i10-index: 912) in high-impact scientific journals, including British Medical Journal (BMJ) (IF 107), Nature Reviews Disease Primers (IF 81), Nature Biotechnology (IF 68), Cancer Cell (IF 50), Journal of Clinical Oncology (IF 50), JAMA Oncology (IF 32), Annals of Oncology (IF 51), Molecular Cancer (IF 41), Cell Metabolism (IF 31), Gut (IF 31), Science Immunology (IF 30). Currently, he is an active member of over 30 Editorial Boards, and the Editor-in-Chief of two major journals: Expert Review of Precision Medicine and Drug Development and American Journal of Translational Research. Dr. Cheng received the Arthur Purdy Stout Annual Award from the Society of Surgical Pathologists in recognition of his outstanding contributions to the field of surgical pathology. He also received the Koss Medal Award, the highest award bestowed by the International Society of Urological Pathology (ISUP) for his lifetime achievement in urological pathology. Dr. Cheng is the President-Elect (2023-2025) of the International Society of Urological Pathology (ISUP). Dr. Cheng's research focuses on translational studies of genitourinary cancers and molecular diagnostics of solid tumors